Reporting to the Global Patient Safety (GPS) Therapeutic Area (TA) Head of General Medicines, the Senior Director is a key role that contributes to the success of Regeneron’s novel gene therapy approach. This position serves as the primary contact within the TA for all safety-related issues for the assigned compound(s) focusing mainly on supporting the advancement and commercialization of our gene therapy portfolio.
<<Volver a la información del trabajo